Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
microMend® logo — Designed to replace sutures and staples, microMend PRO devic...

microMend®

Designed to replace sutures and staples, microMend PRO devices are the ideal solution for healthcare professionals

Founded 2011 United States Seattle, United States 11 employees Series B Total: $15.93M Biotechnology, Health Care +2

General Information

Company Name microMend®
Founded Year 2011
Location United States Seattle, United States
Employees 11
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with microMend®. To contact microMend®, visit micromendskinclosure.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does microMend® compare?

A PDF of microMend® and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting microMend® soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About microMend®

microMend® by KitoTech Medical is a Seattle-based biotechnology startup that offers a groundbreaking wound closure solution. The microMend PRO devices are designed to replace sutures and staples, catering to healthcare professionals as an ideal alternative. With a founding year of 2011, this innovative product has garnered attention in the healthcare, biotechnology, and manufacturing industries. The recent $2.00M Series B investment from Keiretsu Capital in December 2021 has significantly boosted the company's growth. microMend PRO effectively closes wounds up to 50 cm in length and has proven successful for various laceration types, including those with jagged edges. Its efficacy, combined with ease of application, has led to superior clinical results and improved patient experiences, ultimately leading to reduced procedure costs. The startup's emphasis on addressing unmet clinical needs indicates promising scalability in the healthcare market. Overall, microMend PRO's disruptive technology, coupled with strategic investments, positions the company for continued success in the medical device domain.

Business keywords: medical device, wound closure, suturing alternative, clinical effectiveness, patient experience, surgical equipment, dermatology, emergency medicine, surgical procedures, medical device company, wound care, surgical tools, cost-effective healthcare solutions

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $2.00M 1
Keiretsu Capital
Keiretsu Capital
06 Dec 2021
Convertible Note $4.50M -
10 Mar 2021
Convertible Note $3.00M 3
Keiretsu Capital Grand Angels
Keiretsu Capital, Grand Angels +1
01 Aug 2020
Convertible Note $1.50M -
22 Nov 2019
Convertible Note $3.00M -
07 Feb 2019
Venture Round $1.93M -
05 Nov 2018
Convertible Note Undisclosed 1
Thynk Capital
25 Jun 2018

microMend® Alternatives & Competitors

View All Alternatives
microMend® vs
GI Windows Surgical
GI Windows Surgical United States

Engineering less invasive solutions for both surgeons and patients.

Venture round
21 employees
Biotechnology, Health Care
microMend® vs
Lungpacer Medical
Lungpacer Medical Canada

Dedicated to natural breathing by empowering patients to wean off mechanical ventilation and breathe...

Venture round
58 employees
Biotechnology, Health Care
microMend® vs
FritzFinn
FritzFinn United States

Do Good Things

5 employees
Biotechnology, Health Care
View all alternatives

FAQ About microMend®

Designed to replace sutures and staples, microMend PRO devices are the ideal solution for healthcare professionals
microMend® was founded in 2011.
microMend® is headquartered in Seattle, United States.
microMend® operates in Biotechnology, Health Care, Manufacturing and Medical Devices. Its work centres on medical device, wound closure, suturing alternative and clinical effectiveness.
microMend® has approximately 11 employees.
microMend® has completed 7 funding rounds, raising a total of $15.93M. The latest funding stage is Series B.
Top alternatives and competitors to microMend® include GI Windows Surgical, Lungpacer Medical, FritzFinn, AventaMed, CP Medical, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
microMend® and GI Windows Surgical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for microMend®, https://bouncewatch.com/company/micromend, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes